In the discovery of novel antibody based drugs, Alligator uses its proprietary technology platforms ALLIGATOR-GOLD® and FIND®: ALLIGATOR-GOLD® is a synthetic svFv library containing several billion distinct fully human antibodies. FIND® (Fragment Induced Diversity) is an antibody optimization technology based on single-stranded DNA allowing generation of antibodies with significant clinical benefits. Alligator Bioscience AB was founded in 2001 and is a privately held company located at Medicon Village in Lund, Sweden.
- Bli medlem
- Om SwedenBIO